Home » Stocks » PAVmed

PAVmed Inc. (PAVM)

Stock Price: $1.93 USD 0.04 (2.12%)
Updated Oct 27, 2020 4:00 PM EDT - Market closed
After-hours: $1.97 +0.04 (2.07%) Oct 27, 4:58 PM

Stock Price Chart

Key Info

Market Cap 96.70M
Revenue (ttm) n/a
Net Income (ttm) -29.38M
Shares Out 50.10M
EPS (ttm) -0.77
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 27, 2020
Last Price $1.93
Previous Close $1.89
Change ($) 0.04
Change (%) 2.12%
Day's Open 1.87
Day's Range 1.85 - 1.95
Day's Volume 339,131
52-Week Range 0.81 - 3.45

More Stats

Market Cap 96.70M
Enterprise Value 106.12M
Earnings Date (est) Nov 12, 2020
Ex-Dividend Date n/a
Shares Outstanding 50.10M
Float 39.77M
EPS (basic) -0.74
EPS (diluted) -0.77
FCF / Share -0.37
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 3.56M
Short Ratio 5.90
Short % of Float 8.94%
Beta 0.03
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 17.73
Revenue n/a
Operating Income -18.10M
Net Income -29.38M
Free Cash Flow -16.36M
Net Cash -9.42M
Net Cash / Share -0.19
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -141.92%
ROE -3,048.66%
ROIC 954.10%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (2)

Buy 2
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(159.07% upside)
Current: $1.93
Target: 5.00
*Average 12-month price target from 2 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Operating Income-14.30-10.56-8.03-5.65-1.78
Net Income-16.46-17.97-9.52-5.65-1.78
Shares Outstanding30.2022.2813.5012.9711.28
Earnings Per Share-0.54-0.81-0.71-0.44-0.16
Operating Cash Flow-13.36-8.79-6.61-4.45-1.25
Capital Expenditures-0.03-0.03-0.01-0.02-
Free Cash Flow-13.38-8.81-6.61-4.48-1.25
Cash & Equivalents6.228.221.540.590.77
Total Debt8.147.901.94--
Net Cash / Debt-1.920.32-0.410.590.77
Book Value-3.82-2.31-2.85-0.320.63
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name PAVmed Inc.
Country United States
Employees 15
CEO Lishan Aklog

Stock Information

Ticker Symbol PAVM
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: PAVM
IPO Date April 28, 2016


PAVmed operates as a medical device company in the United States. The company's lead product pipeline includes CarpX, a percutaneous device to treat carpal tunnel syndrome; EsoCheck, an non-invasive cell collection device and DNA biomarkers to detect esophageal cancer precursor; PortIO, an implantable intraosseous vascular access device; and DisappEAR, an antimicrobial resorbable ear tube. Its product pipeline also comprises NextCath, a self-anchoring catheter; NextFlo, a disposable infusion system; and Caldus, a disposable tissue ablation device. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was founded in 2014 and is based in New York, New York.